Latest profit margin for Thorne Healthtech: 7.82% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2023
Trailing 12 months ending Jun 2023
Thorne Healthtech (THRN) currently reports a profit margin of 7.82% as of June 2023. That compares with 0.88% in the prior-year period — up 788.9% year over year. That is below the Consumer Discretionary sector average of 10.26%. Use the charts on this page to explore Thorne Healthtech's profit margin history and peer comparisons.
Thorne Healthtech's profit margin increased from 0.88% to 7.82% — a 788.9% year-over-year increase (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Thorne Healthtech's profit margin of 7.82% is lower than the Consumer Discretionary sector average of 10.26%. That is roughly 23.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Thorne Healthtech's current 7.82% should be judged against Consumer Discretionary norms (sector average: 10.26%) and against THRN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 7.82%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Consumer Discretionary average is 10.26%. From there, open related valuation or income-statement pages for Thorne Healthtech, and consider following THRN for alerts when major investors trade the stock.